Whatever happened to M&A fees?
UK public M&A work is down, as are fees. But as the deals markets shows signs of life, it’s not just the M&A titans that are winning There have been a few promising moments in the public M&A market in the past six months, a highlight being US pharmaceutical giant Pfizer’s series of aggressive takeover […]